Cubic News

Cubic Health Articles

Another Blockbuster Falls: Generic Plavix® Now Available

February 2012

After over 8 years of patent challenges between the Canadian generic manufacturing company Apotex and the product’s innovator, sanofi-aventis, clopidogrel (generic for Plavix®) received its Notice of Compliance from Health Canada and is now available on the market in Canada – up View post

---

NOC Watch – Mozobil, Resotran

February 2012

Mozobil™ (plerixafor injection) Mozobil™ is a new drug that has been approved for use in conjunction with another agent, granulocyte-colony stimulating factor (G-CSF), for patients with certain blood cancers (i.e. non-Hodgkin’s lymphoma or multiple myeloma). The combination allows their own blood-derived stem View post

---

Protecting Your Plan from the Gravy Train

February 2012

Although full-product direct-to-consumer advertising (DTCA) is illegal in Canada, most Canadians are exposed to this type of advertising through media spillage from the United States. Everyone is familiar with the often parodied commercials: 10 seconds of smiling couples happily holding hands, while View post

---

Fighting The Battle: Narcotic Abuse Ontario

December 2011

On November 1, 2011, Ontario’s “Narcotics Safety and Awareness Act” came into force.  This new legislation is intended to support the development of a narcotics monitoring database – the first component of Ontario’s new “Narcotics Strategy”, and one of five key elements View post

---

NOC Watch – Sublinox, Generic Latanoprost

December 2011

Sublinox® (Zolpidem) Already approved in several countries, including the Netherlands and the U.S., where it is sold under the familiar trade name Ambien®, Sublinox® is the first zolpidem product available in Canada.  Sublinox® is a non-benzodiazepine sleep aid indicated for the short-term View post

---